RWB.CN (Red White & Bloom CNQ) down 33.33% to C$0.01 on 17 Mar 2026: watch support

RWB.CN stock opened market hours on 17 Mar 2026 trading down 33.33% to C$0.01, with 128,000 shares changing hands and a day high of C$0.02. The move pushed the name back to its year low of C$0.01 after a previous close of C$0.02. Traders reacted to thin liquidity and weak fundamentals, including EPS -0.11 and a negative PE. We examine valuation, technical support, sector context and short-term price targets to explain why the decline makes RWB.CN a high-risk, high-volatility candidate for active traders and analysts.

Intraday drop and trading facts for RWB.CN stock

RWB.CN stock fell 33.33% on 17 Mar 2026, trading between C$0.01 and C$0.02 during market hours. Volume reached 128,000 versus an average of 225,185, producing a relative volume of 0.57. The low float and 470,221,901 shares outstanding amplify moves on modest flows.

RWB.CN stock valuation and financial ratios

Red White & Bloom (RWB.CN) posts EPS -0.11 and a trailing PE of -0.09, reflecting losses. Market cap stands at C$4,702,219.00. Key ratios show weak cash generation: price to sales 0.07, price to book -0.02, and current ratio 1.74. These metrics signal deep valuation stress versus sector averages and limited earnings coverage.

Meyka AI rates RWB.CN with a score out of 100 and forecast

Meyka AI rates RWB.CN with a score out of 100: 73.12 (B+) — BUY. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst consensus. Meyka AI’s forecast model projects a monthly target of C$0.01 and a quarterly target of C$0.03. Compared with the current price C$0.01, the quarterly projection implies an implied upside of 200.00%. Forecasts are model-based projections and not guarantees. These grades are not guaranteed and we are not financial advisors.

Technical picture and levels to watch for RWB.CN stock

Technicals show momentum weak but not exhausted: RSI 40.24 and ADX 30.54 indicating a trend. Short-term resistance sits near the 50-day average C$0.02 and the 200-day average C$0.03. Support is the year low at C$0.01; a sustained break below would raise liquidation risk. Watch MACD and OBV for confirming flows.

Sector context and peers affecting RWB.CN stock

RWB.CN operates in the Healthcare sector and the drug manufacturers specialty industry, a group under pressure with average sector metrics showing volatile margins. Compared with sector average current ratios and ROE, Red White & Bloom trails on cash flow and profitability, increasing relative risk versus larger cannabis peers.

Risks, catalysts and trading strategy for RWB.CN stock

Principal risks include ongoing negative operating cash flow, long inventory days and negative operating margins. Catalysts that could change momentum are timely earnings (next announcement 16 Jul 2026), asset sales, or a liquidity event. For traders, risk management with tight stops and small position sizing is essential given low liquidity and historical drawdowns.

Final Thoughts

RWB.CN stock closed market hours on 17 Mar 2026 at C$0.01, down 33.33%, driven by low liquidity and weak fundamentals including EPS -0.11 and negative cash flow metrics. Meyka AI’s models show a short-term quarterly projection of C$0.03, implying 200.00% upside from today’s price, while a conservative near-term floor remains C$0.01. Our view frames RWB.CN as a speculative, high-volatility ticker suitable for traders who accept deep downside risk and strict position limits. Sector headwinds in healthcare and specialty drug manufacturing add pressure versus peers. Monitor the upcoming earnings date 16 Jul 2026, changes in liquidity, and any corporate actions; those events will likely decide whether the stock stabilizes toward the model’s C$0.03 quarterly forecast or slides below the year low. Meyka AI, an AI-powered market analysis platform, provides this data-driven context to help active investors weigh risk and opportunity. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.